DEA Plans Hearing on Federal Marijuana Rescheduling
"Discover how the upcoming DEA hearing to reconsider the classification of marijuana under US narcotics regulation could spark a major shift in national cannabis policy. The hearing aims to assess expert opinions on transitioning cannabis to a Controlled Substances Act Schedule III drug. This marks the first review in over 50 years."